Determinants of Survival and the Effect of Portosystemic Shunting in Patients with Budd-Chiari Syndrome

Hepatology

Volumn 39, Issue 2, 2004, Pages 500-508

  Murad, Sarwa Darwish ^a   Valla, Dominique Charles ^b   De Groen, Piet C ^c   Zeitoun, Guy ^d   Hopmans, Judith A M ^a   Haagsma, Elizabeth B ^e   Van Hoek, Bart ^f   Hansen, Bettina E ^a   Rosendaal, Frits R ^f   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BEAUJON HOSPITAL   (France)

^c MAYO CLINIC   (United States)

^d HÔPITAL LOUIS MOURIER   (France)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; BRAIN DISEASE; BUDD CHIARI SYNDROME; CLINICAL TRIAL; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LIVER VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARAMETER; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RISK; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HEPATIC VEIN THROMBOSIS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PORTASYSTEMIC SHUNT, SURGICAL; PROGNOSIS; RISK FACTORS;

EID: 10744232260     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20064     Document Type: Article

References (32)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla D. Budd-Chiari syndrome: a review of an expert panel. J Hepatol 2003;38:364-371.
2. Panis Y, Belghiti J, Valla D, Benhamou JP, Fekete F. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 1994;115:276-281.
3. Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, Janssen HL. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 2001;35:338-343.
4. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 2002;22:5-14.
5. Mahmoud AE, Mendoza A, Meshikhes AN, Olliff S, West R, Neuberger J, Buckels J, et al. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. Qjm 1996;89:37-43.
6. Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, Sood GK, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994;73:21-36.
7. Valla D, Hadengue A, el Younsi M, Azar N, Zeitoun G, Boudet MJ, Molas G, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. HEPATOLOGY 1997;25:814-9.
8. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-2368.
9. Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 2000;232:340-352.
10. Bismuth H, Sherlock DJ. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 1991;214:581-589.
11. Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996;171:176-180; discussion 180-181.
12. Ganger DR, Klapman JB, McDonald V, Matalon TA, Kaur S, Rosenblate H, Kane R, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol 1999;94:603-608.
13. Blum U, Rossle M, Haag K, Ochs A, Blum HE, Hauenstein KH, Astinet F, et al. Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1995;197:805-811.
14. Slakey DP, Klein AS, Venbrux AC, Cameron JL. Budd-Chiari syndrome: current management options. Ann Surg 2001;233:522-527.
15. Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999;44:568-574.
16. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, Boudet MJ, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. HEPATOLOGY 1999;30:84-89.
17. Wang ZG, Zhu Y, Wang SH, Pu LP, Du YH, Zhang H, Yuan C, et al. Recognition and management of Budd-Chiari syndrome: report of one hundred cases. J Vasc Surg 1989;10:149-156.
18. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. HEPATOLOGY 1998;28:1191-1198.
19. Kohli V, Pande GK, Dev V, Reddy KS, Kaul U, Nundy S. Management of hepatic venous outflow obstruction. Lancet 1993;342:718-722.
20. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. HEPATOLOGY 2000;31:587-591.
21. Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, Borst HG, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. HEPATOLOGY 1995;21:1337-1344.
22. Tsiotos GG, Nagorney DM, de Groen PC. Selective management of hepatic venous outflow obstruction. J Gastrointest Surg 1997;1:377-385.
23. Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, Maillard JN, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985;103:329-334.
24. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, Benhamou JP. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994;106:1042-1047.
25. Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denic C, Mallet A, Levy VG, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39:496-501.
26. Perello A, Carcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, Reverter JC, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. HEPATOLOGY 2002;35:132-139.
27. Rossle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998;18:73-89.
28. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, venoportal cirrhosis, and large regenerative nodules. HEPATOLOGY 1998;27:488-496.
29. Min AD, Atillasoy EO, Schwartz ME, Thiim M, Miller CM, Bodenheimer HC Jr. Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg 1997;3:423-429.
30. Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992;174:453-459.
31. Sakai Y, Wall WJ. Liver transplantation for Budd-Chiari syndrome: a retrospective study. Surg Today 1994;24:49-53.
32. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990;211:43-49.